Journals / Turkish Journal of Urology / 2018 / Cilt: 44 - Sayı: 1

The association between variant urothelial histologies, pathological stage and disease specific survival in patients with bladder cancer

Pages
24–30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Meanwhile, pathological disease stage and existence of VH were found tobe associated with decreased DSS in the multivariate model.Conclusion: The present study revealed that VH is associated with advanced pathological tumor stage at RCand decreased DSS compared to patients with PUH in patients with BC.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We aimed to compare the oncological outcomes of patients with variant urothelial histologies(VH) with pure urothelial histology (PUH) in bladder cancer (BC) patients.Material and methods: This study includes 223 patients who underwent radical cystectomies (RCs) betweenSeptember 2006 and July 2016 with complete follow-up data A retrospective screening was performedto identify the patients with PUH and VH.
📊
Key Findings & Data:Kaplan-Meier (KM) method was used for survival analysis and log-rank test was used for comparisonof survival rates.
💡
Conclusion & Impact:Meanwhile, pathological disease stage and existence of VH were found tobe associated with decreased DSS in the multivariate model.Conclusion: The present study revealed that VH is associated with advanced pathological tumor stage at RCand decreased DSS compared to patients with PUH in patients with BC.
🔬Design:Modeling & Simulation
📍Scope:2006 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: We aimed to compare the oncological outcomes of patients with variant urothelial histologies(VH) with pure urothelial histology (PUH) in bladder cancer (BC) patients.Material and methods: This study includes 223 patients who underwent radical cystectomies (RCs) betweenSeptember 2006 and July 2016 with complete follow-up data A retrospective screening was performedto identify the patients with PUH and VH. The primary outcomes of interest were pathological stageof disease at RC and disease-specific survival (DSS). For comparison of categorical variables, Fisher’s exacttest and Pearson chi- square and for continuous variables Wilcoxon rank-sum and Mann-Whitney U testswere used. Kaplan-Meier (KM) method was used for survival analysis and log-rank test was used for comparisonof survival rates. Predictors of survival were detected with mulitivariable Cox-proportional hazardsmodel including the variables such as gender, age, existence of VH, lymph node dissection (LND) type andpathological stage of the disease.Results: A moderate-degree correlation was detected between VH and pathological stages of RC (r=0.45,p<0.001). In PUH group, 39 (25.8%) of 151 patients died after a median follow-up of 20 (0-107) months;whereas 37 (51.4%) of 72 patients with VH died after a median follow-up of 16.5 (0-104) months (p<0.001).In terms of pathological stage, the number of patients with PUH and VH were at stages pT0-2 (n=100; 66.2%vs. n=19; 26.4%), pT3-4 (n=35; 23.2% vs. 38; 52.8%, and in 16 (10.6%) and 15 (20.8%) patients with LN positivity,respectively (p<0.001). KM survival analysis revealed a significantly decreased DSS in patients withVH compared to PUH (p<0.001). Meanwhile, pathological disease stage and existence of VH were found tobe associated with decreased DSS in the multivariate model.Conclusion: The present study revealed that VH is associated with advanced pathological tumor stage at RCand decreased DSS compared to patients with PUH in patients with BC.

🔖

Cite This Article

BÖYÜK, A., ŞANLI, M. Ö., ERDEM, S., TEFİK, T., ÖZCAN, F., ÖZLÜK, M. Y., KILIÇARSLAN, I., TUNÇ, M. (2018). The association between variant urothelial histologies, pathological stage and disease specific survival in patients with bladder cancer. Turkish Journal of Urology, Cilt: 44 - Sayı: 1, 24–30. https://ajindex.com/articles/379622

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015
  2. E359-86. Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. Eur Urol 2017
  3. [CrossRef] Mahdavifar N, Ghoncheh M, Pakzad R, Momenimovahed Z, Salehiniya H. Epidemiology, Incidence and Mortality of Bladder Cancer and their Relationship with the Development Index in the World. Asian Pac J Cancer Prev 2016
  4. [CrossRef] Aydin S, Boz MY. Rapid changes in the incidence of urinary sys- tem cancers in Turkey. Turk J Urol 2015
  5. [CrossRef] Svatek RS, Hollenbeck BK, Holmang S, Lee R, Kim SP, Stenzl A, et al. The economics of bladder cancer: costs and considerations of caring for this disease. Eur Urol 2014
  6. [CrossRef] Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M, Nielsen ME, et al. Bladder cancer. Nat Rev Dis Primers 2017
  7. 17022. [CrossRef] Willis D, Kamat AM. Nonurothelial bladder cancer and rare vari- ant histologies. Hematol Oncol Clin North Am 2015
  8. [CrossRef] Mitra AP, Bartsch CC, Bartsch G, Jr., Miranda G, Skinner EC, Daneshmand S. Does presence of squamous and glandular dif- ferentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis. Urol Oncol 2014
  9. [CrossRef] Kim SP, Frank I, Cheville JC, Thompson RH, Weight CJ, Thapa P, et al. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma. J Urol 2012
  10. [CrossRef] Ploeg M, Aben KK, Hulsbergen-van de Kaa CA, Schoenberg MP, Witjes JA, Kiemeney LA. Clinical epidemiology of nonurothelial bladder cancer: analysis of the Netherlands Cancer Registry. J Urol 2010
  11. [CrossRef] Shapur NK, Katz R, Pode D, Shapiro A, Yutkin V, Pizov G, et al. Is radical cystectomy mandatory in every patient with variant histology of bladder cancer. Rare Tumors 2011
  12. e22. Monn MF, Kaimakliotis HZ, Pedrosa JA, Cary KC, Bihrle R, Cheng L, et al. Contemporary bladder cancer: variant histology may be a significant driver of disease. Urol Oncol 2015
  13. e5-20. Rogers CG, Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Lotan Y, et al. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transit